Do you want to read an article? Please log in or register.
Monitoring and management of fibrosing interstitial lung diseases: a narrative review for practicing clinicians
Further Publications
RECOMMENDED
Related content
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med.
Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M, INBUILD trial investigators.
doi: 10.1016/S2213-2600(20)30036-9.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Fibrotic interstitial lung diseases and air pollution: a systematic literature review
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir Rev.
Harari S, Raghu G, Caminati A, Cruciani M, Franchini M, Mannucci P
doi: 10.1183/16000617.0093-2020.
RECOMMENDED
Interstitial Lung Disease
Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
doi: 10.1016/j.chest.2020.03.037.
RECOMMENDED
Interstitial Lung Disease
A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Ryerson CJ, Corte TJ, Myers JL, Walsh SLF, Guler SA
doi: 10.1183/13993003.00276-2021
RECOMMENDED
Interstitial Lung Disease
The psychometric properties of the King's Brief Interstitial Lung Disease questionnaire and thresholds for meaningful treatment response in patients with progressive fibrosing interstitial lung diseases
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J
Birring SS, Bushnell DM, Baldwin M, Mueller H, Male N, Rohr KB, Inoue Y
doi: 10.1183/13993003.01790-2021
Interstitial Lung Disease
Filamin A (FLNA) mutation-A newcomer to the childhood interstitial lung disease (ChILD) classification
Pediatr Pulmonol.
Shelmerdine SC, Semple T, Wallis C, Aurora P, Moledina S, Ashworth MT, Owens CM
doi: 10.1002/ppul.23695.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Progression of fibrosing interstitial lung disease
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res.
Wong AW, Ryerson CJ, Guler SA
doi: 10.1186/s12931-020-1296-3.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
The natural history of progressive fibrosing interstitial lung diseases
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
★ 2
Recommended by
Dr Martin Frey, Faculty Member
doi: 10.1183/13993003.00085-2020.
RECOMMENDED
Interstitial Lung Disease
The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med.
Atienza-Mateo B, Remuzgo-Martínez S, Mora Cuesta VM, Iturbe-Fernández D, Fernández-Rozas S, Prieto-Peña D, Calderón-Goercke M, Corrales A, Blanco Rodríguez GB, Gómez-Román JJ, González-Gay MÁ, Cifrián JM
doi: 10.3390/jcm9061606.